Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
76 Cards in this Set
- Front
- Back
- 3rd side (hint)
Antiplatelet agents?
|
Aspirin
Thienopyridine Agents Dipyridamole Glycoprotein IIb/IIIa Inhbitors |
|
|
Aspirin MoA?
|
Irreversible inhibition of platelet cyclooxygenase-1 -> Blocking of the formation of TxA2 from arachidonic acid -> decreased platelet aggregation
|
Astra is a Cock Blocker, Forming from Archaic Autistic Texans
|
|
Lifespan of platelets?
|
7 days
|
|
|
PKs of Aspirin
|
Rapid absorption in stomach and upper intestine; platelet inhibition after 1 hr of ingestion which takes effect for lifespan of platelet
|
|
|
Main thienopyridine?
|
clopidogrel
|
Theo Clops along with the Dog
|
|
Clopidogrel MoA?
|
irreversible inhibition of ADP pathway receptor antagonist to inhibit platelet aggregation
|
Chloe Angrily Decides Peter Must Be Stopped
|
|
Clopidogrel has no sig effect on the synthesis of what two products?
|
TxA2 & prostacyclin
|
Texas Protons
|
|
Dipyridamole MoA?
|
Vasodilatior that inhibits platelet function by inhibiting adenosine uptake and cGMP phosphodiesterase activity which is reversible
|
The Pyramids Were Slow TO Build for Queen Esther
|
|
Dipyridamole bioavail: low or high?
|
low
|
|
|
Dipyridamole clinical use:
|
Used with aspirin to prevent cerebrovascular ischemia (Aggrenox)
Ltd to no effect mono |
|
|
AEs of dipyridamole?
|
Headache and bleeding not a/w dypyridamole alone
|
|
|
Primary Glycoprotein IIb/IIIa inhibitor?
|
Abciximab
|
I Glide My Finger over the Axim
|
|
Abciximab (Glycoprotein IIb/IIIa inhibitor) MoA?
|
inhibits formation of platelet thrombi by inhibiting activated receptors from binding with fibrinogen and forming bridges between activated platelets
|
Andy Stops Bitches from Getting over Fiborous Bridges
|
|
AEs of Abciximab (Glycoprotein IIb/IIIa inhibitors)?
|
thrombocytopenia (low platelet count)
bleeding hypersensity rxn with 2nd dose |
|
|
Abciximab is what kind of molecule?
|
Antibody which destroys platelets via antibody action
|
|
|
Anticoag agts?
|
Unfractioned heparin
Low molecular weight heparin Direct thrombin inhibitors Warfarin |
|
|
suffix for all LMWHs?
|
-parin or -parinux
|
|
|
Coag cascade purpose?
|
formation of clots to stop bleeding
|
|
|
Unfractioned Heparin MoA?
|
Binds to antithrombin III (ATIII) -> enhanced activity
ATIII binds to factors |
|
|
What clotting factors does ATIII bind to and inhibit?
|
IIa (PT), IXa, Xa, XIa, & XIIa
|
|
|
Which pathway does ATIII inhibit?
|
Intrinsic
|
|
|
What does UH not affect?
|
formed thrombi which were present prior to UH therapy which are cleared by physiologic thrombolytic mechanisms and it has no fibrinolytic activity
|
Ursula Fibs and Lies
|
|
What kind of mix is UH and what is the compound?
|
It's heterogenous mix of complex mucopolysaccharides
|
Ursula is snotty
|
|
What portion of heparin molecules are pharmacologically active?
|
Approx 1/3rd
|
|
|
What does UH bind together, what is the complex called, and what happens after they bind?
|
It binds ATIII with clotting enzyme; forms a ternary complex formation; it then dissociates and starts again
|
|
|
What is the change UH induces in the ternary complex called?
|
Conformational change
|
|
|
What are direct thrombin inhibitors not?
|
clot busters
|
|
|
What are the 2 routes for UH?
|
SQ or IV
|
|
|
Half-life of UH?
|
1-2 hrs in healthy adults
|
|
|
Metabolism of UH?
|
hepatic heparinases (still slightly renal)
|
|
|
What happens to UH 1/2 life in renally impaired pts?
|
It's slightly prolonged; not diazyble
|
|
|
How is UH given?
|
First bolus, then maintainence dosing
|
|
|
What is UH dosage based on?
|
weight
|
|
|
What is monitored after UH admin?
|
activated partial thromboplastin time (aPTT)
|
|
|
What is aPTT sensitive to?
|
Inhibitory effects of heparin on thrombin, factor Xa & XIa
|
|
|
What do you maintain aPTT after bolus?
|
1.5x-2.5x reference
|
|
|
AEs of UH?
|
Bleeding (increases w/ dose and duration)
Low platelet count |
|
|
Cx of UH?
|
Aspirin
|
|
|
How does Low Molecular Weight Heparin (LMWH) differ from UH?
|
It's homogenous, has superior PK profile, doesn't need lab monitoring, and has decreased anti IIa activity relative to anti-Xa activity (more selective for Xa)
|
|
|
What is the mean mol weight of LMWH?
|
4000-5000 daltons
|
|
|
How does the ATIII binding action differ in UH versus LMWH?
|
LMWH ATIII binds much less to thrombin relative to factor Xa
|
|
|
Why are LMWH agts not interchangable?
|
Due to different PK and different ratios of Anti-Xa:IIa action.
|
|
|
What is the preferred LMWH agt? what is its Anti-Xa:IIa activity?
|
enoxaparin; 3.8:1
|
|
|
General PKs of LMWH?
|
SQ admin almost 100 percent bioavail
Peak effects occur 3-5 hours after admin Renal dose adjustment required |
|
|
AEs of LMWH?
|
Bleeding
Low platelet count Injection site rxn(thrombocytophlebitis) |
|
|
What reverses heparin action?
|
Protamine
|
|
|
How does Protamine reverse heparin action?
|
Forms a stable, inactive complex by ionically binding w/ heparin
|
|
|
What 2 factors are involved in the efficacy of protamine reversal of heparin?
|
Dosage (should be 1 mg protamine:~100 units of heparin)
Less effective with LMWH |
|
|
PKs of protamine?
|
Onset within 5 minutes; duration is 2 hours
|
|
|
AEs of protamine?
|
anaphylaxis
Heparin rebound (antithrombin activity of heparin returns even with effective dose) |
|
|
Direct thrombin inhibitor agts and MoA?
|
Lepirudin, bivalirudin, & agratroban; block either the active site or both active site and exocite I
|
|
|
How do DTIs bind to thrombin?
|
inhibit free and clot-bound thrombin w/o requiring endogenous cofactors
|
|
|
Half life of DTIs?
|
25-60 mins (short)
|
|
|
-rudins PKs?
|
majority excreted renally
|
|
|
-rudins dosage considerations?
|
insufficient renal function
|
|
|
Agratroban PKs and doseage considerations?
|
Hepat metab; hepatic insuffiency
|
|
|
Unique AE of lepirudin?
|
antibody formation
|
|
|
Drawback of DTIs?
|
no reversal agt
|
|
|
Warfarin MoA?
|
inhibits vitamin K dependent clotting factor synthesis
|
|
|
What are the vitamin K dependent clotting factors and regulatory proteins?
|
Factors II, VII, IX, & X
protein C & S |
|
|
What doesn't warfarin do?
|
dissolve the current clot
|
|
|
Which pathways does warfarin operate on?
|
Extrinsic (factors VII& X) and common (prothrombin (II))
|
|
|
Warfarin PKs?
|
100 % absorption
Hepatic metabolism through 3A4 & 2C9 Long 1/2 life 99 % protein binding |
|
|
Warfarin monitoring?
|
Internation Normalized Ratio (INR) which is pts PTT over normal PTT raised to the power of the ISI value (1-1.4)
|
|
|
When initiating warfarin, what should it over lap with and for how long?
|
It should overlap w/ heparin for about 4 days until INR is therapeutic for 2 days
|
|
|
Warfarin dosing?
|
Highly individualized (PKs [particularly 2C9 & 3A4 inx] and PDs)
|
|
|
What population should never be given warfarin and why?
|
Pregnant women. It's preg cat X.
|
|
|
D-D interactions of warfarin that decrease coag?
|
Additive anticoag effect w/ APAP
EtOH acute ingestion -> increased INR -> inhibition (increased bleed) Antimicrobials (fluoroquinolones) -> greater anticoag |
|
|
D-D interactions of warfarin that increase coag?
|
EtOH chronic ingestion -> increased INR -> induction (decreased bleed)
Carbamazapine is 3A4 inducer -> need much higher warfarin |
|
|
Pharmacodynamic interactions with warfarin?
|
anti-thyriod meds -> reduced thryoid function -> reduced warfarin effect
|
|
|
Reversal of warfarin is through what?
|
Vitamin K
|
|
|
MoA of Vit K reversal of warfarin?
|
factor II, VII, IX, & X dependent upon Vitamin K
|
|
|
Vitamin K route?
|
All 4.
|
|
|
Best routes of Vitamin K?
|
PO (absorbed in duodenum)
SQ (readily absorbed) IV (fastest onset) |
|
|
Vitamin K onset of action?
|
PO: 6-12 h
Parenteral: 1-2 h |
|
|
Vitamin K AE?
|
Hypersensitivity w/ IV & IM route (rash, sometimes lethal), especially if admin is rapid
|
|